Publication Date:
2015-03-31
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Denning, David W -- Bromley, Michael J -- Medical Research Council/United Kingdom -- New York, N.Y. -- Science. 2015 Mar 27;347(6229):1414-6. doi: 10.1126/science.aaa6097. Epub 2015 Mar 26.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. The National Aspergillosis Centre, University Hospital of South Manchester, Manchester, UK. ddenning@manchester.ac. ; The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. The Manchester Fungal Infection Group, The University of Manchester, Manchester, UK.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/25814567" target="_blank"〉PubMed〈/a〉
Keywords:
Antifungal Agents/*therapeutic use
;
Aspergillosis/*drug therapy/*mortality
;
Aspergillus fumigatus/*drug effects/genetics/isolation & purification
;
Asthma/microbiology
;
Cystic Fibrosis/microbiology
;
*Drug Design
;
Drug Resistance, Fungal/genetics
;
Humans
;
Pulmonary Disease, Chronic Obstructive/microbiology
;
Voriconazole/*pharmacology/therapeutic use
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
